You are here

Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
University of British Columbia
Vancouver, British Columbia, V5Z 1M9 Canada
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Asthma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Inclusion Criteria:

- generally healthy, men and women with mild allergic asthma, aged 18 to 60 years

- only asthma med is short-acting bronchodilator used not more than twice weekly

- FEV1 greater than 70% predicted and a demonstrated baseline late response to allergen
induction

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00410280
Pfizer
Completed
Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Asthma
NCT00150397
All Genders
18+
Years
Multiple Sites
Asthma
NCT00723021
All Genders
18+
Years
Multiple Sites
Asthma
NCT00425061
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now